文献速递神经创伤神经重症

创伤性急性硬膜下血肿的功能与患者报告结局及院内费用:神经外科悖论

Functional and patient-reported outcome versus in-hospital costs after traumatic acute subdural hematoma (t-ASDH): a neurosurgical paradox?
PubMed 文献 · Acta Neurochir (Wien) · 2019-03-28

该回顾性研究纳入108例连续创伤性急性硬膜下血肿患者,采用格拉斯哥结局评分和QOLIBRI问卷评估结局,按荷兰指南计算院内费用。结果显示死亡率随TBI严重程度增加而升高,但幸存者QOLIBRI评分在严重程度组间相似,院内费用较高且主要与TBI严重程度、入院和手术相关。

要点

  • 108例患者中,轻度、中度和重度TBI死亡率分别为23%、47%和61%,良好结局率分别为72%、47%和29%。
  • 幸存者平均QOLIBRI评分在轻度、中度和重度TBI组分别为61、61和64,组间相似。
  • 院内总费用平均为€24,980,急诊手术后为€28,670,加用ICP监测时为€36,580。

核心结论

  • 研究证实创伤性急性硬膜下血肿后结局常为「不良好」,但即使最严重损伤患者也可获得「良好」结局。
  • 院内治疗费用较高,主要与TBI严重程度相关,入院和手术是主要费用驱动因素。
  • 这些结果为进一步研究创伤性急性硬膜下血肿手术治疗的价值导向成本效果提供基础。

研究设计与样本

  • 回顾性研究,连续纳入108例创伤性急性硬膜下血肿患者。
  • 采用格拉斯哥结局评分和TBI特异性QOLIBRI问卷评估患者结局,按荷兰费用计算指南计算院内费用。

主要发现

  • 108例中,轻度(GCS 13-15)40例、中度(GCS 9-12)19例、重度(GCS 3-8)49例。
  • 死亡率随TBI严重程度增加而升高:轻度23%、中度47%、重度61%;良好结局(GOS 4-5)率分别为72%、47%、29%。
  • 幸存者平均QOLIBRI评分在轻度、中度和重度组分别为61、61和64,组间相似。
  • 院内费用平均为€24,980,急诊手术后为€28,670,加用ICP监测时为€36,580。

关键数值与推荐

  • TBI严重程度按GCS分组:轻度13-15分,中度9-12分,重度3-8分。
  • 良好结局定义为GOS 4-5分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The decision whether to operate or not in patients with a traumatic acute subdural hematoma (t-ASDH) can, in many cases, be a neurosurgical dilemma. There is a general conception that operating on severe cases leads to the survival of severely disabled patients and is associated with relatively high medical costs. There is however little information on the quality of life of patients after operation for t-ASDH, let alone on the cost-effectiveness. METHODS: This study retrospectively investigated patient outcome and in-hospital costs for 108 consecutive patients with a t-ASDH. Patient outcome was assessed using the Glasgow Outcome Score (GOS) and the Traumatic Brain Injury (TBI)-specific QOLIBRI questionnaire. The in-hospital costs were calculated using the Dutch guidelines for costs calculation. RESULTS: Out of 108 patients, 40 were classified as having sustained a mild (Glasgow Coma Scale (GCS) 13-15), 19 a moderate (GCS 9-12), and 49 a severe (GCS 3-8) TBI. As expected, mortality rates increased with higher TBI severity (23%, 47%, and 61% respectively), whereas the chance for favorable outcome (GOS 4-5) decreased (72%, 47%, and 29%). Interestingly, the mean QOLIBRI scores for survivors were quite similar between the TBI severity groups (61, 61, and 64). Healthcare consumption and in-hospital costs increased with TBI severity. In-hospital costs were relatively high (€24,980), especially after emergency surgery (€28,670) and when additional ICP monitoring was used (€36,580). CONCLUSIONS: Although this study confirms that outcome is often "unfavorable" after t-ASDH, it also shows that "favorable" outcome can be achieved, even in the most severely injured patients. In-hospital treatment costs were substantial and mainly related to TBI severity, with admission and surgery as main cost drivers. These results serve as a basis for necessary future research focusing on the value-based cost-effectiveness of surgical treatment of patients with a t-ASDH.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. van Dijck JTJM, van Essen TA, Dijkman MD, et al. Functional and patient-reported outcome versus in-hospital costs after traumatic acute subdural hematoma (t-ASDH): a neurosurgical paradox? Acta Neurochir (Wien). 2019. PMID: 30923919. doi:10.1007/s00701-019-03878-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。